Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AUDENZ™ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) safely and effectively. See full prescribing information for AUDENZ. AUDENZ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted)injectable emulsion for intramuscular use Initial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-other
AUDENZTM is an inactivated vaccine indicated for active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. AUDENZ is approved for use in persons 6 months of age and older at increased risk of exposure to the influenza A H5N1 virus subtype contained in the vaccine.
- generic_name
- influenza a virus h5n1 whole
- product_names
- influenza a virus h5n1 whole
- ndc
- 70461-700, 70461-700-04, 70461-700-03, 70461-800, 70461-800-41, 70461-800-40
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en